Cancer BiologybioRxivPreprint
Novel small-molecule inhibitors of the protein kinase DYRK: Potential Therapeutic candidates in cancer
Prabhadevi Venkataramani, Elad Elkayam, Ankur Garg…·Nicholas K. Tonks
This study identifies two selective DYRK1A inhibitors, FC-2 and FC-3, which show antitumor effects in glioblastoma models.
DOI 10.1101/2025.11.05.686653